Cargando…
ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides
Recent studies have linked the activity of ER aminopeptidase 2 (ERAP2) to increased efficacy of immune-checkpoint inhibitor cancer immunotherapy, suggesting that pharmacological inhibition of ERAP2 could have important therapeutic implications. To explore the effects of ERAP2 inhibition on the immun...
Autores principales: | Temponeras, Ioannis, Stamatakis, George, Samiotaki, Martina, Georgiadis, Dimitris, Pratsinis, Harris, Panayotou, George, Stratikos, Efstratios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836666/ https://www.ncbi.nlm.nih.gov/pubmed/35163832 http://dx.doi.org/10.3390/ijms23031913 |
Ejemplares similares
-
Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein
por: Stamatakis, George, et al.
Publicado: (2021) -
Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism
por: Maben, Zachary, et al.
Publicado: (2021) -
Author Correction: Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism
por: Maben, Zachary, et al.
Publicado: (2023) -
The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I
por: Mavridis, George, et al.
Publicado: (2021) -
Can ERAP1 and ERAP2 Form Functional Heterodimers? A Structural Dynamics Investigation
por: Papakyriakou, Athanasios, et al.
Publicado: (2022)